These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30061399)

  • 1. Acetyl-l-carnitine deficiency in patients with major depressive disorder.
    Nasca C; Bigio B; Lee FS; Young SP; Kautz MM; Albright A; Beasley J; Millington DS; Mathé AA; Kocsis JH; Murrough JW; McEwen BS; Rasgon N
    Proc Natl Acad Sci U S A; 2018 Aug; 115(34):8627-8632. PubMed ID: 30061399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry.
    Liu X; Zheng P; Zhao X; Zhang Y; Hu C; Li J; Zhao J; Zhou J; Xie P; Xu G
    J Proteome Res; 2015 May; 14(5):2322-30. PubMed ID: 25784130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of metabotropic glutamate receptor 2/3 expression by the NF-kappaB pathway in primary dorsal root ganglia neurons: a possible mechanism for the analgesic effect of L-acetylcarnitine.
    Chiechio S; Copani A; De Petris L; Morales ME; Nicoletti F; Gereau RW
    Mol Pain; 2006 Jun; 2():20. PubMed ID: 16764720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated tumor necrosis factor-alpha receptor subtype 1 and the association with abnormal brain function in treatment-resistant depression.
    Huang MH; Chen MH; Tu PC; Bai YM; Su TP; Yang BH; Liu RS; Li CT
    J Affect Disord; 2018 Aug; 235():250-256. PubMed ID: 29660639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated specific peripheral cytokines found in major depressive disorder patients with childhood trauma exposure: a cytokine antibody array analysis.
    Lu S; Peng H; Wang L; Vasish S; Zhang Y; Gao W; Wu W; Liao M; Wang M; Tang H; Li W; Li W; Li Z; Zhou J; Zhang Z; Li L
    Compr Psychiatry; 2013 Oct; 54(7):953-61. PubMed ID: 23639406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidimensional predictors of antidepressant responses: Integrating mitochondrial, genetic, metabolic and environmental factors with clinical outcomes.
    Nasca C; Barnhill O; DeAngelis P; Watson K; Lin J; Beasley J; Young SP; Myoraku A; Dobbin J; Bigio B; McEwen B; Rasgon N
    Neurobiol Stress; 2021 Nov; 15():100407. PubMed ID: 34815985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carnitine and/or Acetylcarnitine Deficiency as a Cause of Higher Levels of Ammonia.
    Maldonado C; Guevara N; Queijo C; González R; Fagiolino P; Vázquez M
    Biomed Res Int; 2016; 2016():2920108. PubMed ID: 26998483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-Carnitine and Acetyl-L-Carnitine: Potential Novel Biomarkers for Major Depressive Disorder.
    Nie LJ; Liang J; Shan F; Wang BS; Mu YY; Zhou XH; Xia QR
    Front Psychiatry; 2021; 12():671151. PubMed ID: 34658942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia.
    Balercia G; Regoli F; Armeni T; Koverech A; Mantero F; Boscaro M
    Fertil Steril; 2005 Sep; 84(3):662-71. PubMed ID: 16169400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetics and energetics in ventral hippocampus mediate rapid antidepressant action: Implications for treatment resistance.
    Bigio B; Mathé AA; Sousa VC; Zelli D; Svenningsson P; McEwen BS; Nasca C
    Proc Natl Acad Sci U S A; 2016 Jul; 113(28):7906-11. PubMed ID: 27354525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls.
    Kurita H; Maeshima H; Kida S; Matsuzaka H; Shimano T; Nakano Y; Baba H; Suzuki T; Arai H
    J Affect Disord; 2013 Apr; 146(2):205-12. PubMed ID: 23102506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-Acetylcarnitine in dysthymic disorder in elderly patients: a double-blind, multicenter, controlled randomized study vs. fluoxetine.
    Bersani G; Meco G; Denaro A; Liberati D; Colletti C; Nicolai R; Bersani FS; Koverech A
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1219-25. PubMed ID: 23428336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma acetyl-l-carnitine and l-carnitine in major depressive episodes: a case-control study before and after treatment.
    Ait Tayeb AEK; Colle R; El-Asmar K; Chappell K; Acquaviva-Bourdain C; David DJ; Trabado S; Chanson P; Feve B; Becquemont L; Verstuyft C; Corruble E
    Psychol Med; 2023 Apr; 53(6):2307-2316. PubMed ID: 35115069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study.
    Kuwano N; Kato TA; Setoyama D; Sato-Kasai M; Shimokawa N; Hayakawa K; Ohgidani M; Sagata N; Kubo H; Kishimoto J; Kang D; Kanba S
    J Affect Disord; 2018 Apr; 231():74-82. PubMed ID: 29454180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind, multicenter trial comparing acetyl l-carnitine with placebo in the treatment of fibromyalgia patients.
    Rossini M; Di Munno O; Valentini G; Bianchi G; Biasi G; Cacace E; Malesci D; La Montagna G; Viapiana O; Adami S
    Clin Exp Rheumatol; 2007; 25(2):182-8. PubMed ID: 17543140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prefrontal cortical GABA abnormalities are associated with reduced hippocampal volume in major depressive disorder.
    Abdallah CG; Jackowski A; Sato JR; Mao X; Kang G; Cheema R; Coplan JD; Mathew SJ; Shungu DC
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1082-90. PubMed ID: 25983019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The therapeutic potential of acetyl-L-carnitine in the treatment of cognitive and depressive disorders in the elderly].
    Gavrilova SI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(6. Vyp. 2):37-45. PubMed ID: 30346432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid Peroxidation and Immune Biomarkers Are Associated with Major Depression and Its Phenotypes, Including Treatment-Resistant Depression and Melancholia.
    Sowa-Kućma M; Styczeń K; Siwek M; Misztak P; Nowak RJ; Dudek D; Rybakowski JK; Nowak G; Maes M
    Neurotox Res; 2018 Feb; 33(2):448-460. PubMed ID: 29103192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma metabolome analysis of patients with major depressive disorder.
    Kawamura N; Shinoda K; Sato H; Sasaki K; Suzuki M; Yamaki K; Fujimori T; Yamamoto H; Osei-Hyiaman D; Ohashi Y
    Psychiatry Clin Neurosci; 2018 May; 72(5):349-361. PubMed ID: 29356314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the reference range of endogenous plasma carnitines in healthy adults.
    Reuter SE; Evans AM; Chace DH; Fornasini G
    Ann Clin Biochem; 2008 Nov; 45(Pt 6):585-92. PubMed ID: 18782814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.